Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases

Flavio M Ceci1, Mauro Ceccanti2, Carla Petrella3

  • 1Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

Insights

Moderate alcohol consumption may lower atherosclerotic neuro-cardiovascular disease (ACVD) risk by increasing high-density lipoprotein (HDL) cholesterol. However, heavy drinking and genetic factors like apolipoprotein E4 can increase ACVD risk, meaning moderate drinking benefits aren't universal.

Area of Science:

  • Cardiovascular Science
  • Genetics
  • Nutritional Science

Background:

  • Lipoprotein disorders are key risk factors for atherosclerotic neuro-cardiovascular disease (ACVD).
  • Lifestyle factors, particularly alcohol consumption, significantly influence ACVD risk.
  • Moderate alcohol intake is associated with higher high-density lipoprotein (HDL) cholesterol and lower ACVD risk compared to abstinence.

Purpose of the Study:

  • To investigate the complex relationship between alcohol consumption, lipid profiles, and ACVD risk.
  • To explore the influence of genetic polymorphisms on alcohol's impact on ACVD.
  • To determine if the protective effects of moderate drinking extend to all individuals.

Main Methods:

  • Literature review of studies examining alcohol intake, lipid serum profiles, and ACVD.
  • Analysis of genetic polymorphisms (Apolipoprotein E, Interleukin-6, CETP) in relation to alcohol consumption and ACVD risk.
  • Examination of ethanol's effects on lipid profiles and endothelial function.

Main Results:

  • Heavy alcohol consumption is linked to increased ACVD risk and adverse changes in lipid profiles.
  • Genetic factors, including Apolipoprotein E4, IL-6-174, and CETP TaqIB polymorphisms, may exacerbate ACVD risk in heavy drinkers.
  • The cardioprotective association of moderate drinking, mediated by HDL cholesterol, is not universally applicable due to genetic variations.

Conclusions:

  • While moderate alcohol intake may offer some cardiovascular protection, this benefit is not universal.
  • Genetic predispositions can modify the relationship between alcohol consumption and ACVD risk.
  • Heavy drinking poses a significant risk for ACVD, potentially amplified by specific genetic profiles.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
600
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
448
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
98
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.9K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
319
Hypothesis Test for Test of Independence01:16

Hypothesis Test for Test of Independence

The test of independence is a chi-square-based test used to determine whether two variables or factors are independent or dependent. This hypothesis test is used to examine the independence of the variables. One can construct two qualitative survey questions or experiments based on the variables in a contingency table. The goal is to see if the two variables are unrelated (independent) or related (dependent). The null and alternative hypotheses for this test are:
H0: The two variables (factors)...
5.6K